Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(15):1129-1131; doi:10.1093/jnci/93.15.1129
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by McIntosh, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McIntosh, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 15, 1129-1131, August 1, 2001
© 2001 Oxford University Press

NEWS

Government-Industry Collaborations Explored for Alternative Medicine

Phyllis McIntosh

As more and more Americans turn to complementary and alternative medicine, cooperation between the National Institutes of Health and the companies and organizations that produce, market, and help ensure the quality of CAM therapies is essential if the public is to get reliable information on their safety and efficacy.

That was the conclusion of those attending the first-ever colloquium to explore opportunities for cooperation between NIH’s National Center for Complementary and Alternative Medicine and the CAM therapeutics industry. The colloquium brought together more than 200 representatives of industry, research communities, third-party payers, consumers, government agencies, and . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?